insulin
Eli Lilly returns to RTP with $470M plant for diabetes drugs
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) plans to build a production facility in RTP, creating 462 jobs over the next five years,
Read More
Lilly to cut insulin price; Novo Nordisk offers options
Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to Chairman and CEO Dave Ricks. Meanwhile, Novo Nordisk, which operates a huge insulin manufacturing plant in Johnston County, says it offers a variety of means to help patients reduce costs.
Read More
Report: Democrats want answers from Novo Nordisk, others on insulin pricing
Leaders of two House committees have sent letters to Novo Nordisk and two other drug giants seeking information abut increasing costs of insulin, according to CNBC.
Read MoreInsulin pricing under review as Congress begins hearings on drug prices
A senior Republican lawmaker said Tuesday he plans to investigate price spikes in the cost of insulin for people with diabetes as Congress opened hearings on the high cost of prescription drugs.
Read More
Novo Nordisk strengthens diabetes treatment arsenal with $800M deal
Novo Nordisk, which operates a huge and growing manufacturing facility in Johnston County, is expanding its capabilities for treatment of diabetes with the acquisition of a U.K. startup and much of its technology in a deal that could be worth as much as $800 million.
Read More
